Medtronic set its second quarter fiscal year 2022 cash dividend.
The Latest
As spine procedures continue to accelerate to the outpatient setting, surgeons will need access to technologies that enable higher-acuity procedures to be done with accuracy and predictability in the least traumatic manner.
Casey Davidson, MD, performed the Southeast region's first surgery with NuVasive's Modulus ALIF 3D-printed titanium implant.
J. Christopher Barry has spent his career focused in the medical technology industry at Medtronic and currently CEO of NuVasive.
From outgoing leaders to new board members, here are nine updates on executive leadership at spine and orthopedic device companies in the last 60 days.
Eight more operating rooms are being added to Hunterdon Medical Center in Flemington, N.J., including two ORs that will be used specifically for spine and total joint surgeries, Mycentraljersey.com reported Aug. 19.
The U.S. Court of Appeals for the Federal Circuit on Aug. 18 refused to revive claims in a NuVasive spine surgery patent case, siding with a previous decision made by the Patent Trial and Appeal Board.
The minimally invasive spinal implants market reached nearly $2 billion in 2020, and it's expected to hit close to $3 billion by 2027, according to iData Research.
Ortho Regenerative Technologies has extended its clinical hold on its Ortho-R drug, according to an Aug. 20 news release.
Alex Gorsky will step down as chair and CEO of Johnson & Johnson and serve as executive chairman effective Jan. 3, 2022.